Molecular characteristics of rhesus macaque interleukin‐22: cloning, in vitro expression and biological activities
Open Access
- 21 February 2018
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 154 (4) , 651-662
Abstract
Summary: Interleukin‐22 (IL‐22) is a potential therapeutic agent for diseases driven by epithelial injury. To characterize the IL‐22 expressed by rhesus macaques, animals that are irreplaceable for human disease research, rhesus macaque IL‐22 (rhIL‐22) was cloned and expressed, and its biological activity and in vivo distribution were examined. It was found that the rhIL‐22 gene consists of five introns and six exons, including a short non‐coding exon starting 22 bp downstream of a putative TATA box. The amino acid sequence of rhIL‐22 showed 95·5% identity to that of humans, and it shared two conserved disulphide bonds, three N‐glycosylation sites and all the critical residues for binding to IL‐22R1. High levels of IL‐22 mRNA were observed in the liver, pancreas, lymphoid tissues and especially in the outer‐body barriers such as the intestinal tract of rhesus macaques. Functionally, purified rhIL‐22 has a similar but a little earlier effect on signal transducer and activator of transcription 3 phosphorylation at Tyr705 compared with that of commercial human IL‐22. The expression of the antibacterial proteins β‐defensin‐2, S100A8, S100A9, RegIIIα and Muc1 by HT‐29 cells was largely upregulated after stimulation with rhIL‐22. Recombinant rhIL‐22 could also significantly promote the proliferation of human intestinal epithelial cells without affecting cell apoptosis. These data indicate that rhesus macaque IL‐22 is highly similar to that of humans in both structure and function, and tests of therapeutic effects of human IL‐22 on human diseases in rhesus macaques are warranted.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2013ZX10001004‐002‐001)
This publication has 37 references indexed in Scilit:
- Interleukin-22 Promotes Proliferation of Liver Stem/Progenitor Cells in Mice and Patients With Chronic Hepatitis B Virus InfectionGastroenterology, 2012
- Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infectionMucosal Immunology, 2012
- The Membrane-Bound Mucin Muc1 Regulates T Helper 17-Cell Responses and Colitis in MiceGastroenterology, 2012
- Mechanisms of Rapid Induction of Interleukin-22 in Activated T Cells and Its Modulation by Cyclosporin AJournal of Biological Chemistry, 2012
- The Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid CellsImmunity, 2012
- Lymphotoxin Controls the IL-22 Protection Pathway in Gut Innate Lymphoid Cells during Mucosal Pathogen ChallengeCell Host & Microbe, 2011
- Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22Nature Immunology, 2011
- Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protectionCytokine & Growth Factor Reviews, 2010
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cellsNature Immunology, 2009
- IL-22 mediates mucosal host defense against Gram-negative bacterial pneumoniaNature Medicine, 2008